These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3728190)

  • 1. Correlations between purine levels, clinical and immunological status in ADA deficiency.
    Simmonds HA; Fairbanks LD; Morris GS; Hugh-Jones K; Morgan G; Levinsky RJ
    Adv Exp Med Biol; 1986; 195 Pt A():93-9. PubMed ID: 3728190
    [No Abstract]   [Full Text] [Related]  

  • 2. New perspectives in the diagnosis and treatment of adenosine deaminase (ADA) deficiency.
    Levinsky RJ; Davies EG; Simmonds HA; Webster DR; Adinolfi M
    Adv Exp Med Biol; 1984; 165 Pt A():33-8. PubMed ID: 6609527
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean.
    Giblett ER
    Ciba Found Symp; 1978; (68):3-18. PubMed ID: 115664
    [No Abstract]   [Full Text] [Related]  

  • 4. Purine metabolism and immunodeficiency: urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency.
    Simmonds HA; Sahota A; Potter CF; Cameron JS
    Clin Sci Mol Med; 1978 May; 54(5):579-84. PubMed ID: 108044
    [No Abstract]   [Full Text] [Related]  

  • 5. Complete adenosine deaminase (ADA) deficiency without immunodeficiency, and primary hyperoxaluria, in a 12-year-old boy.
    Perignon JL; Hamet M; Cartier P; Griscelli C
    Adv Exp Med Biol; 1980; 122A():403-8. PubMed ID: 6968500
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T; Gruchalska E
    Acta Haematol Pol; 1979; 10(3):205-10. PubMed ID: 116467
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary excretion of purines, purine nucleosides, and pseudouridine in adenosine deaminase deficiency.
    Mills GC; Goldblum RM; Newkirk KE; Schmalstieg FC
    Biochem Med; 1978 Oct; 20(2):180-99. PubMed ID: 736910
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid prenatal diagnosis of adenosine deaminase deficiency and other purine disorders using foetal blood.
    Simmonds HA; Fairbanks LD; Webster DR; Rodeck CH; Linch DC; Levinsky RJ
    Biosci Rep; 1983 Jan; 3(1):31-8. PubMed ID: 6839009
    [No Abstract]   [Full Text] [Related]  

  • 9. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase.
    Cohen A; Gudas LJ; Ullman B; Martin DW
    Ciba Found Symp; 1978; (68):101-14. PubMed ID: 115659
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
    Zegers BJ; Stoop JW
    Clin Biochem; 1983 Feb; 16(1):43-7. PubMed ID: 6407780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine deaminase activity in a series of 19 patients with the Diamond-Blackfan syndrome.
    Whitehouse DB; Hopkinson DA; Pilz AJ; Arredondo FX
    Adv Exp Med Biol; 1986; 195 Pt A():85-92. PubMed ID: 3728189
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased purine nucleotides in adenosine deaminase-deficient lymphocytes.
    Schmalstieg FC; Nelson JA; Mills GC; Monahan TM; Goldman AS; Goldblum RM
    J Pediatr; 1977 Jul; 91(1):48-51. PubMed ID: 195028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine deaminase deficiency and severe combined immunodeficiency disease.
    Thompson LF; Seegmiller JE
    Adv Enzymol Relat Areas Mol Biol; 1980; 51():167-210. PubMed ID: 6255772
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency.
    Cowan MJ; Martin DW; Wara DW; Ammann AJ
    Adv Exp Med Biol; 1984; 165 Pt A():39-45. PubMed ID: 6609530
    [No Abstract]   [Full Text] [Related]  

  • 16. Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients.
    Markert ML; Hershfield MS; Schiff RI; Buckley RH
    J Clin Immunol; 1987 Sep; 7(5):389-99. PubMed ID: 3116034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cell function and recycling of purines.
    Giblett ER
    N Engl J Med; 1976 Dec; 295(24):1375-6. PubMed ID: 824556
    [No Abstract]   [Full Text] [Related]  

  • 18. Red cell metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy.
    Staal GE; Stoop JW; Zegers BJ; van der Vlist MJ; de Bruyn CH; Wadman SK
    Monogr Hum Genet; 1978; 10():104-7. PubMed ID: 102921
    [No Abstract]   [Full Text] [Related]  

  • 19. S-Adenosylhomocysteine hydrolase activity in a lymphoblastoid cell line from a patient with adenosine deaminase dificiency disease.
    Tsuchiya S; Nakae S; Konno T; Tada K
    J Inherit Metab Dis; 1981; 4(4):197-201. PubMed ID: 6796770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early prenatal investigation of a pregnancy at risk of adenosine deaminase deficiency using chorionic villi.
    Aitken DA; Gilmore DH; Frew CA; Ferguson-Smith ME; Carty MJ; Chatfield WR
    J Med Genet; 1986 Feb; 23(1):52-4. PubMed ID: 3950935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.